D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 17.3 CNY 3.9%
Market Cap: 19.7B CNY
Have any thoughts about
DaShenLin Pharmaceutical Group Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one DaShenLin Pharmaceutical Group Co Ltd stock under the Base Case scenario is 44.5 CNY. Compared to the current market price of 17.3 CNY, DaShenLin Pharmaceutical Group Co Ltd is Undervalued by 61%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
44.5 CNY
Undervaluation 61%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation Backtest
DaShenLin Pharmaceutical Group Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DaShenLin Pharmaceutical Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DaShenLin Pharmaceutical Group Co Ltd?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Retail Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about DaShenLin Pharmaceutical Group Co Ltd

Provide an overview of the primary business activities
of DaShenLin Pharmaceutical Group Co Ltd.

What unique competitive advantages
does DaShenLin Pharmaceutical Group Co Ltd hold over its rivals?

What risks and challenges
does DaShenLin Pharmaceutical Group Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DaShenLin Pharmaceutical Group Co Ltd.

Provide P/S
for DaShenLin Pharmaceutical Group Co Ltd.

Provide P/E
for DaShenLin Pharmaceutical Group Co Ltd.

Provide P/OCF
for DaShenLin Pharmaceutical Group Co Ltd.

Provide P/FCFE
for DaShenLin Pharmaceutical Group Co Ltd.

Provide P/B
for DaShenLin Pharmaceutical Group Co Ltd.

Provide EV/S
for DaShenLin Pharmaceutical Group Co Ltd.

Provide EV/GP
for DaShenLin Pharmaceutical Group Co Ltd.

Provide EV/EBITDA
for DaShenLin Pharmaceutical Group Co Ltd.

Provide EV/EBIT
for DaShenLin Pharmaceutical Group Co Ltd.

Provide EV/OCF
for DaShenLin Pharmaceutical Group Co Ltd.

Provide EV/FCFF
for DaShenLin Pharmaceutical Group Co Ltd.

Provide EV/IC
for DaShenLin Pharmaceutical Group Co Ltd.

Show me price targets
for DaShenLin Pharmaceutical Group Co Ltd made by professional analysts.

What are the Revenue projections
for DaShenLin Pharmaceutical Group Co Ltd?

How accurate were the past Revenue estimates
for DaShenLin Pharmaceutical Group Co Ltd?

What are the Net Income projections
for DaShenLin Pharmaceutical Group Co Ltd?

How accurate were the past Net Income estimates
for DaShenLin Pharmaceutical Group Co Ltd?

What are the EPS projections
for DaShenLin Pharmaceutical Group Co Ltd?

How accurate were the past EPS estimates
for DaShenLin Pharmaceutical Group Co Ltd?

What are the EBIT projections
for DaShenLin Pharmaceutical Group Co Ltd?

How accurate were the past EBIT estimates
for DaShenLin Pharmaceutical Group Co Ltd?

Compare the revenue forecasts
for DaShenLin Pharmaceutical Group Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DaShenLin Pharmaceutical Group Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DaShenLin Pharmaceutical Group Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of DaShenLin Pharmaceutical Group Co Ltd compared to its peers.

Compare the P/E ratios
of DaShenLin Pharmaceutical Group Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing DaShenLin Pharmaceutical Group Co Ltd with its peers.

Analyze the financial leverage
of DaShenLin Pharmaceutical Group Co Ltd compared to its main competitors.

Show all profitability ratios
for DaShenLin Pharmaceutical Group Co Ltd.

Provide ROE
for DaShenLin Pharmaceutical Group Co Ltd.

Provide ROA
for DaShenLin Pharmaceutical Group Co Ltd.

Provide ROIC
for DaShenLin Pharmaceutical Group Co Ltd.

Provide ROCE
for DaShenLin Pharmaceutical Group Co Ltd.

Provide Gross Margin
for DaShenLin Pharmaceutical Group Co Ltd.

Provide Operating Margin
for DaShenLin Pharmaceutical Group Co Ltd.

Provide Net Margin
for DaShenLin Pharmaceutical Group Co Ltd.

Provide FCF Margin
for DaShenLin Pharmaceutical Group Co Ltd.

Show all solvency ratios
for DaShenLin Pharmaceutical Group Co Ltd.

Provide D/E Ratio
for DaShenLin Pharmaceutical Group Co Ltd.

Provide D/A Ratio
for DaShenLin Pharmaceutical Group Co Ltd.

Provide Interest Coverage Ratio
for DaShenLin Pharmaceutical Group Co Ltd.

Provide Altman Z-Score Ratio
for DaShenLin Pharmaceutical Group Co Ltd.

Provide Quick Ratio
for DaShenLin Pharmaceutical Group Co Ltd.

Provide Current Ratio
for DaShenLin Pharmaceutical Group Co Ltd.

Provide Cash Ratio
for DaShenLin Pharmaceutical Group Co Ltd.

What is the historical Revenue growth
over the last 5 years for DaShenLin Pharmaceutical Group Co Ltd?

What is the historical Net Income growth
over the last 5 years for DaShenLin Pharmaceutical Group Co Ltd?

What is the current Free Cash Flow
of DaShenLin Pharmaceutical Group Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for DaShenLin Pharmaceutical Group Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
DaShenLin Pharmaceutical Group Co Ltd

Current Assets 11.5B
Cash & Short-Term Investments 2.8B
Receivables 1.9B
Other Current Assets 6.8B
Non-Current Assets 14B
Long-Term Investments 197.7m
PP&E 7.4B
Intangibles 5.4B
Other Non-Current Assets 911.6m
Current Liabilities 12.3B
Accounts Payable 3.1B
Accrued Liabilities 471.6m
Short-Term Debt 5.8B
Other Current Liabilities 2.9B
Non-Current Liabilities 6.1B
Long-Term Debt 4.8B
Other Non-Current Liabilities 1.3B
Efficiency

Earnings Waterfall
DaShenLin Pharmaceutical Group Co Ltd

Revenue
25.9B CNY
Cost of Revenue
-17B CNY
Gross Profit
8.9B CNY
Operating Expenses
-7.4B CNY
Operating Income
1.5B CNY
Other Expenses
-597.6m CNY
Net Income
906.7m CNY

Free Cash Flow Analysis
DaShenLin Pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

DaShenLin Pharmaceutical Group Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 3-Year Average ROE
Positive Revenue Growth Forecast
55/100
Profitability
Score

DaShenLin Pharmaceutical Group Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

DaShenLin Pharmaceutical Group Co Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average D/E
Average Altman Z-Score
45/100
Solvency
Score

DaShenLin Pharmaceutical Group Co Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
DaShenLin Pharmaceutical Group Co Ltd

Wall Street analysts forecast DaShenLin Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DaShenLin Pharmaceutical Group Co Ltd is 27.34 CNY with a low forecast of 18.69 CNY and a high forecast of 35.7 CNY.

Lowest
Price Target
18.69 CNY
8% Upside
Average
Price Target
27.34 CNY
58% Upside
Highest
Price Target
35.7 CNY
106% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DaShenLin Pharmaceutical Group Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DaShenLin Pharmaceutical Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

DaShenLin Pharmaceutical Group Co Ltd

Country

China

Industry

Retail

Market Cap

19.7B CNY

Dividend Yield

0%

Description

DaShenLin Pharmaceutical Group Co., Ltd. engages in the retail and wholesale of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 38,353 full-time employees. The company went IPO on 2017-07-31. The firm's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The firm mainly conducts its business within domestic market.

Contact

GUANGDONG
Guangzhou
No. 410, 410-1, Longxi Avenue, Liwan District
+862081689688
www.dslyy.com

IPO

2017-07-31

Employees

38 353

Officers

GM & Director
Mr. Guoqiang Ke
Financial Controller
Mr. Guangzhi Peng
Deputy GM & Director
Ms. Qun Fei Tan
Secretary of the Board
Mr. Run Shi Liang
Chairman of Supervisory Board & Deputy Director of Human Resources Department - Guangdong Province
Mr. Zhi Hui Chen

See Also

Discover More
What is the Intrinsic Value of one DaShenLin Pharmaceutical Group Co Ltd stock?

The intrinsic value of one DaShenLin Pharmaceutical Group Co Ltd stock under the Base Case scenario is 44.5 CNY.

Is DaShenLin Pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 17.3 CNY, DaShenLin Pharmaceutical Group Co Ltd is Undervalued by 61%.

Back to Top